Taro 2001 News Archive

Trademarks and Copyright© The images and information contained in the Site are, to the fullest extent possible, copyrighted and otherwise proprietary. It is the policy of Taro to enforce its intellectual property rights to the fullest extent of the law, including (where applicable) seeking criminal sanctions.

10/12/2001

Taro to Report Results and Conduct Conference Call On October 18, 2001

Hawthorne, NY, October 12, 2001 -- Taro Pharmaceutical Industries Ltd. (Nasdaq/NMS:TARO), today reported that the Company intends to announce financial results for the third quarter ended September 30, 2001 prior to the Nasdaq market opening on Thursday, October 18, 2001. The company will conduct a conference call to discuss the results on the same day at 11:00 a.m. Eastern/8 a.m. Pacific.

The conference call will be hosted by Barrie Levitt, M.D., Chairman of the Company, who will review the quarter along with Kevin Connelly, Chief Financial Officer, and Daniel Saks, Vice President, Corporate Affairs. The call will be available live via the Internet by accessing www.taro.com. For those who cannot listen to the live broadcast, an online replay will be available until October 22, 2001 on www.taro.com. A phone replay will be available through October 22, 2001, by dialing 800-475-6701 (domestic) or 320-365-3844 (international) and entering the passcode 607309.

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.